Clara Vicente Garces
Investigador pre-doc
Research group
Researcher Clara Vicente graduated in Biomedical Sciences in 2017 from the University of Barcelona and received her master's degree in Clinical Analysis Laboratory from Pompeu Fabra University in 2018.
At the end of 2018, he joined the Non-malignant Leukemia and Hematopoietic Group as a research assistant after completing the Masters internship in this group.
He is currently in this group working on mass sequencing techniques and other molecular techniques, and will begin his doctorate in the application of these techniques in the diagnosis of leukemias.
SJD Barcelona Children's Hospital Last Publications
- Esperanza-Cebollada E, Gomez-Gonzalez S, Pérez-Jaume S, Vega-García N, Vicente-Garces C, Richarte M, Rives-Solà S, Català-Temprano A, Torrebadell-Burriel M and Camós-Guijosa M A miRNA signature related to stemness identifies high-risk patients in paediatric acute myeloid leukaemia BRITISH JOURNAL OF HAEMATOLOGY . 202(1): 96-110.
- Vicente-Garces C, Maynou-Fernández J, Fernandez-Isern G, Esperanza-Cebollada E, Torrebadell-Burriel M, Català-Temprano A, Rives-Solà S, Camós-Guijosa M and Vega-García N Fusion InPipe, an integrative pipeline for gene fusion detection from RNA-seq data in acute pediatric leukemia Frontiers in Molecular Biosciences . 10: 1141310-1141310.
- Vicente-Garces C, Esperanza-Cebollada E, Montesdeoca S, Torrebadell-Burriel M, Rives-Solà S, Dapena JL, Català-Temprano A, Conde N, Camós-Guijosa M and Vega-García N Technical Validation and Clinical Utility of an NGS Targeted Panel to Improve Molecular Characterization of Pediatric Acute Leukemia Frontiers in Molecular Biosciences . 9: 854098-854098.
Projects
- Project name:
- SGR 2022-2024_Grup de recerca en tumors del desenvolupament
- Leader
- Jaume Mora Graupera
- Funding entities:
- Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca
- Code
- 2021 SGR 01612
- Starting - finishing date:
- 2022 - 2025
- Project name:
- Análisis de los factores pronósticos de fracaso del tratamiento tras terapia con células T con receptores antigénicos quiméricos (CAR-T) en pacientes pediátricos con leucemia linfoblástica aguda de línea B
- Leader
- Susana Rives Solà, Montserrat Torrebadell Burriel
- Funding entities:
- Instituto de Salud Carlos III (ISCIII), Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD
- Code
- PI21/00218
- Starting - finishing date:
- 2022 - 2024
- Project name:
- Nuevas técnicas para la caracterización molecular completa y la mejora del seguimiento de la enfermedad mínima residual en leucemia aguda pediátrica
- Leader
- Mireia Camós Guijosa, Nerea Vega García
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI21/00213
- Starting - finishing date:
- 2022 - 2024